Pure Global

Drug-coated stent for the treatment of coronary artery disease - Vietnam Registration 2301008ĐKLH/BYT-HTTB

Access comprehensive regulatory information for Drug-coated stent for the treatment of coronary artery disease in Vietnam's medical device market through Pure Global AI's free database. This Risk Class TTBYT Loại D medical device is registered under number 2301008ĐKLH/BYT-HTTB and manufactured by Theo theo phụ lục.

This page provides complete technical specifications, regulatory compliance details, 1 companies making similar products including Hemoteq AG, and 1 recent registrations in the same category. Pure Global AI offers free access to 300,000+ Vietnamese medical device registrations, helping global MedTech companies navigate Vietnam MOH regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
300,000+ Devices
1 Competitors
1 Recent Registrations
2301008ĐKLH/BYT-HTTB
Registration Details
Vietnam MOH Registration: 2301008ĐKLH/BYT-HTTB
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

Drug-coated stent for the treatment of coronary artery disease
VN: Bóng nong mạch vành phủ thuốc Paclitaxel
Risk Class TTBYT Loại D

Registration Details

2301008ĐKLH/BYT-HTTB

18007275/ĐKLH-BYT-TB-CT

Theo theo phụ lục

Theo phụ lục

Company Information

Theo theo phụ lục

Technical Details

• New injuries (mainly in cases of stenosis or occlusion of the organ), including small blood vessels (Small Vessel Disease (SVD)) • Restenosis after percutaneous transluminal coronary angioplasty (PTCA) with balloon or stent (ISR) • Before and after balloon angioplasty in the stent implantation process • Acute or high-risk acute ischemic stroke

Dates and Status

Sep 26, 2023

Companies Making Similar Products
Companies providing products similar to "Drug-coated stent for the treatment of coronary artery disease"